The tumor suppressor BAP1 regulates the Hippo pathway in pancreatic ductal adenocarcinoma

Journal: Cancer Research

Published: 2020-04-15

DOI: 10.1158/0008-5472.can-19-1704

Affiliations: 10

Authors: 18

Go to article
Institutions Share
Department of Discovery Oncology, Genentech, Inc., United States of America (USA) 0.39
Department of Pathology, Genentech, Inc., United States of America (USA) 0.17
Department of Translational Immunology, Genentech, Inc., United States of America (USA) 0.11
Department of Bioinformatics and Computational Biology, Genentech, Inc., United States of America (USA) 0.06
Department of Immunology, Genentech, Inc., United States of America (USA) 0.06
Department of Translational Oncology, Genentech, Inc., United States of America (USA) 0.06
University of Hawai'i Cancer Center (UH Cancer Center), United States of America (USA) 0.06
UCSF Department of Dermatology, United States of America (USA) 0.04
UCSF Department of Pathology, United States of America (USA) 0.04
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.04

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER